Procter & Gamble Health Limited (BSE: 500126)
Health Care · Pharmaceuticals · IN
Rs5,215.55
+1.12% today · -13.8% 1Y
Procter & Gamble Health Limited (BSE: 500126) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $894.55M.
Over the last twelve months the share price has lost 13.8%, trading between 4.70K and 6.96K.
Tweenvest scores Procter & Gamble Health Limited across four factors: quality 90/100, value 83/100, growth 50/100, dividend 84/100. Its strongest factor is quality.
500126 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $894.55M
- Revenue (TTM)
- $151.55M
- P/E
- 27.46
- EPS
- 189.94
- Dividend yield
- 3.01%
- Beta (5Y)
- 0.18
- 52-week high
- Rs6,955.00
- 52-week low
- Rs4,699.70
- Avg volume (3M)
- —
- Shares outstanding
- 16.60M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Alumis Inc.NasdaqGS: ALMS | $926.76M | $7.17 | +0.14% |
| ZhuZhou QianJin Pharmaceutical Co.,LtdSHSE: 600479 | $914.15M | CN¥12.44 | +0.32% |
| Hainan Haiyao Co., Ltd.SZSE: 000566 | $912.29M | CN¥4.71 | +1.95% |
| Bide Pharmatech Co., Ltd.SHSE: 688073 | $906.79M | CN¥70.50 | -7.96% |
| Youcare Pharmaceutical Group Co., Ltd.SHSE: 688658 | $887.89M | CN¥13.38 | -4.70% |
| Kaken Pharmaceutical Co., Ltd.TSE: 4521 | $886.07M | ¥3,705.00 | -1.85% |
| Luye Pharma Group Ltd.SEHK: 2186 | $880.59M | HK$1.73 | -5.46% |
| Mega Lifesciences Public Company LimitedSET: MEGA | $876.99M | ฿33.75 | -2.88% |
Figures last refreshed Oct 11, 2026.